Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
Antibiotic Selection00:57

Antibiotic Selection

48.9K
Overview
48.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects.

Frontiers in immunology·2024
Same author

Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.

Nature communications·2024
Same author

Assessing developability early in the discovery process for novel biologics.

mAbs·2023
Same author

Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes.

Nature communications·2023
Same author

NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine·2023
Same author

<i>In vitro</i> discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom.

mAbs·2022

Related Experiment Video

Updated: May 2, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.2K

Phenotypic directed antibody selection.

John McCafferty1

  • 1IONTAS Ltd., Hopkins Building, Tennis Court Road, Cambridge CB2 1QW, UK.

Chemistry & Biology
|February 25, 2014
PubMed
Summary

Researchers identified two antibodies that protect cells from rhinovirus infection. These antibodies target the rhinovirus 3C protease, preventing cell death and offering a new therapeutic strategy.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Rhinovirus infections cause significant cellular damage and death.
  • Identifying protective mechanisms against viral cytopathy is crucial for therapeutic development.

Purpose of the Study:

  • To develop a "phenotype directed" strategy for identifying neutralizing antibodies against rhinovirus.
  • To isolate antibodies capable of protecting host cells from rhinovirus-induced cell death.

Main Methods:

  • Utilized a large-scale cellular antibody library (10^8 clones).
  • Employed a "phenotype directed" screening approach to select for protective antibodies.
  • Validated antibody efficacy in preventing rhinovirus-mediated cell death.

Main Results:

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.0K
Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
09:07

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

12.3K

Related Experiment Videos

Last Updated: May 2, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.2K
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.0K
Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
09:07

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

12.3K
  • Successfully identified two distinct antibodies from the library.
  • Both antibodies demonstrated efficacy in preventing cell death caused by rhinovirus infection.
  • The identified antibodies share a common viral target: rhinovirus 3C protease.

Conclusions:

  • The "phenotype directed" approach is effective for discovering functional antibodies.
  • Targeting rhinovirus 3C protease with specific antibodies can prevent viral-induced cell death.
  • These findings provide a basis for developing novel antiviral therapies against rhinovirus.